Chondrogenesis of human bone marrow mesenchymal stromal cells in highly porous alginate-foams supplemented with chondroitin sulfate

被引:27
|
作者
Huang, Zhao [1 ]
Nooeaid, Patcharakamon [2 ]
Kohl, Benjamin [1 ]
Roether, Judith A. [3 ]
Schubert, Dirk W. [3 ]
Meier, Carola [1 ]
Boccaccini, Aldo R. [2 ]
Godkin, Owen [1 ]
Ertel, Wolfgang [1 ]
Arens, Stephan [1 ]
Schulze-Tanzil, Gundula [1 ,4 ]
机构
[1] Charite, Dept Orthopaed Trauma & Reconstruct Surg, D-13353 Berlin, Germany
[2] Univ Erlangen Nurnberg, Inst Biomat, Dept Mat Sci & Engn, Erlangen, Germany
[3] Univ Erlangen Nurnberg, Inst Polymer Mat, Dept Mat Sci & Engn, Erlangen, Germany
[4] Paracelsus Med Univ, Inst Anat, Nurnberg, Germany
关键词
Chondrogenesis; Alginate-foam scaffolds; Chondrocytes; Mesenchymal stromal cells; Chondroitin sulfate; ARTICULAR-CARTILAGE LESIONS; IN-VITRO CHONDROGENESIS; PLATELET-RICH PLASMA; ADULT STEM-CELLS; PORE-SIZE; TISSUE; SCAFFOLDS; KNEE; DIFFERENTIATION; CHONDROCYTES;
D O I
10.1016/j.msec.2015.01.082
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
To overcome the limited intrinsic cartilage repair, autologous chondrocyte or bone-marrow-derived mesenchymal stromal cell (BM-MSC) was implanted into cartilage defects. For this purpose suitable biocompatible scaffolds are needed to provide cell retention, chondrogenesis and initial mechanical stability. The present study should indicate whether a recently developed highly porous alginate (Alg) foam scaffold supplemented with chondroitin sulfate (CS) allows the attachment, survival and chondrogenesis of BM-MSCs and articular chondrocytes. The foams were prepared using a freeze-drying method; some of them were supplemented with CS and subsequently characterized for porosity, biodegradation and mechanical profile. BM-MSCs were cultured for 1-2 weeks on the scaffold either under chondrogenic or maintenance conditions. Cell vitality assays, histology, glycosaminoglycan (sGAG) assay, and type II and I collagen immunolabelings were performed to monitor cell growth and extracellular matrix (ECM) synthesis in the scaffolds. Scaffolds had a high porosity similar to 93-95% with a mean pore sizes of 237 +/- 48 mu m (Alg) and 197 +/- 61 mu m (Alg/CS). Incorporation of CS increased mechanical strength of the foams providing gradually CS release over 7 days. Most of the cells survived in the scaffolds. BM-MSCs and articular chondrocytes formed rounded clusters within the scaffold pores. The BM-MSCs, irrespective of whether cultured under non/chondrogenic conditions and chondrocytes produced an ECM containing sGAGs, and types II and I collagen. Total collagen and sGAG contents were higher in differentiated BM-MSC cultures supplemented with CS than in CS-free foams after 14 days. The cell cluster formation induced by the scaffolds might stimulate chondrogenesis via initial intense cell-cell contacts. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:160 / 172
页数:13
相关论文
共 50 条
  • [1] Ectopic osteogenesis and chondrogenesis of bone marrow stromal stem cells in alginate system
    Cai, Xiaoxiao
    Lin, Yunfeng
    Ou, Guomin
    Luo, En
    Man, Yi
    Yuan, Quan
    Gong, Ping
    CELL BIOLOGY INTERNATIONAL, 2007, 31 (08) : 776 - 783
  • [2] Study on the chondrogenesis in vivo of bone marrow stromal cells compounded with alginate gel
    Liu, Lei
    Chen, Runliang
    Lin, Yunfeng
    Li, Cai
    Tian, Weidong
    Li, Shengwei
    BIOCERAMICS, VOL 19, PTS 1 AND 2, 2007, 330-332 : 1145 - +
  • [3] PLEIOTROPHIN COMMITS HUMAN BONE MARROW MESENCHYMAL STROMAL CELLS TOWARDS HYPERTROPHY DURING CHONDROGENESIS
    Chevallier, N.
    Bouderlique, T.
    Henault, E.
    Lebouvier, A.
    Rouard, H.
    Courty, J.
    Albanese, P.
    WOUND REPAIR AND REGENERATION, 2013, 21 (06) : A60 - A60
  • [4] Pleiotrophin Commits Human Bone Marrow Mesenchymal Stromal Cells towards Hypertrophy during Chondrogenesis
    Bouderlique, Thibault
    Henault, Emilie
    Lebouvier, Angelique
    Frescaline, Guilhem
    Bierling, Phillipe
    Rouard, Helene
    Courty, Jose
    Albanese, Patricia
    Chevallier, Nathalie
    PLOS ONE, 2014, 9 (02):
  • [5] Variations in chondrogenesis of human bone marrow-derived mesenchymal stem cells in fibrin/alginate blended hydrogels
    Ma, Kun
    Titan, Ashley L.
    Stafford, Melissa
    Zheng, Chun Hua
    Levenston, Marc E.
    ACTA BIOMATERIALIA, 2012, 8 (10) : 3754 - 3764
  • [6] Distinct Effects of Chondroitin Sulfate on Hematopoietic Cells and the Stromal Microenvironment in Bone Marrow Hematopoiesis
    Katagiri, Takayuki
    Ushiki, Takashi
    Kawasaki, Asami
    Uemura, Shun
    Suwabe, Tatsuya
    Tanaka, Tomoyuki
    Fuse, Kyoko
    Shibasaki, Yasuhiko
    Sone, Hirohito
    Igarashi, Michihiro
    Masuko, Masayoshi
    BLOOD, 2018, 132
  • [7] Distinct effects of chondroitin sulfate on hematopoietic cells and the stromal microenvironment in bone marrow hematopoiesis
    Katagiri, Takayuki
    Uemura, Shun
    Ushiki, Takashi
    Nakajima-Takagi, Yaeko
    Oshima, Motohiko
    Mikami, Tadahisa
    Kawasaki, Asami
    Ishiguro, Hajime
    Tanaka, Tomoyuki
    Sone, Hirohito
    Kitagawa, Hiroshi
    Igarashi, Michihiro
    Iwama, Atsushi
    Masuko, Masayoshi
    EXPERIMENTAL HEMATOLOGY, 2021, 96 : 52 - +
  • [8] Silk fibroin/gelatin-chondroitin sulfate-hyaluronic acid effectively enhances in vitro chondrogenesis of bone marrow mesenchymal stem cells
    Sawatjui, Nopporn
    Damrongrungruang, Teerasak
    Leeanansaksiri, Wilairat
    Jearanaikoon, Patcharee
    Hongeng, Suradej
    Limpaiboon, Temduang
    MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS, 2015, 52 : 90 - 96
  • [9] Mesenchymal stromal/stem cells markers in the human bone marrow
    Rasini, Valeria
    Dominici, Massimo
    Kluba, Torsten
    Siegel, Georg
    Lusenti, Giulia
    Northoff, Hinnak
    Horwitz, Edwin M.
    Schaefer, Richard
    CYTOTHERAPY, 2013, 15 (03) : 292 - 306
  • [10] Improved chondrogenesis of human bone marrow mesenchymal stem cells in transwell cultures
    Murdoch, Alan D.
    Grady, Lisa M.
    Katopodi, Theoni
    Hardingham, Tim E.
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2007, 88 (04) : A56 - A57